Author Question: Epinephrine is a fast-acting neurotransmitter. True or false? A) True B) ... (Read 72 times)

evelyn o bentley

  • Hero Member
  • *****
  • Posts: 564
Epinephrine is a fast-acting neurotransmitter. True or false?
 
  A) True
  B) False

Question 2

A patient is administered morphine. Morphine is a prototypical drug that can be classified in different ways. Which of the following classifications applies to morphine?
 
  A) Central nervous system depressant
  B) Central nervous system stimulant
  C) Anti-inflammatory
  D) Antihypertensive



tsternbergh47

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

B

Answer to Question 2

A
Feedback:
Drugs are classified according to their effects on particular body systems, their therapeutic uses, and their chemical characteristics. For example, morphine can be classified as a central nervous system depressant and a narcotic or opioid analgesic. A central nervous system stimulant increases attention and raises mood. An anti-inflammatory agent decreases inflammation at the site of tissue or joint inflammation. An antihypertensive agent reduces blood pressure.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library